![]() |
市場調查報告書
商品編碼
1856994
全球真菌蛋白肉類替代品市場:未來預測(至2032年)-按產品類型、類型、經營模式、技術、分銷管道、最終用戶和地區進行分析Mycoprotein Meat Substitutes Market Forecasts to 2032 - Global Analysis By Product Type, Type, Business Model, Technology, Distribution Channel, End User and By Geography |
||||||
根據 Stratistics MRC 的數據,預計 2025 年全球真菌蛋白肉類替代品市場規模將達到 17.8 億美元,到 2032 年將達到 38.4 億美元,預測期內複合年成長率為 11.6%。
菌蛋白肉類替代品是一種高蛋白、不含肉類的食品,源自發酵真菌,通常是鐮刀菌(Fusarium vienatum)。菌蛋白透過可控發酵生產,具有與傳統肉類相似的纖維質地和鮮味。這些替代品富含必需氨基酸,飽和脂肪含量低,並且通常添加了營養成分。它們常用於漢堡、雞塊和肉末類產品中,與畜牧業相比,它們所需的資源更少,有助於永續食品生產。菌蛋白產品滿足了素食者、純素食者以及尋求高蛋白替代品的健康消費者的需求。
人們越來越關注紅肉消費與慢性病之間的聯繫
以真菌蛋白為基礎的食品替代品提供了一種極具吸引力的選擇,它富含蛋白質,但飽和脂肪和排放含量卻很低。環境問題也進一步推動了這一轉變,因為真菌蛋白生產的碳足跡遠低於畜牧業。此外,倡導永續蛋白質來源的健康組織和營養師也支持這個市場。因此,真菌肉類替代品的需求在零售和餐飲通路中都日益成長。
味覺和口感的局限性
消費者常常將質地、風味深度和烹飪方法的不一致性列為接受新產品的障礙。在以肉類為主食的文化中,這些限制尤其突出。此外,用於生產菌蛋白的發酵過程可能會賦予產品泥土味或其他不熟悉的氣味,這可能會讓初次購買者望而卻步。儘管改善適口性的研發工作仍在進行中,但克服這些感官障礙對於獲得廣泛的市場認可和提高複購率至關重要。
生技公司與食品製造商的夥伴關係
生物技術新興企業與成熟食品公司之間的策略合作正在為產品開發和擴充性開闢新的可能性。這些合作關係使得精準發酵、菌株最佳化和風味工程能夠融入主流食品生產。合資企業還有助於獲取先進的基礎設施、監管專業知識和全球分銷網路。隨著消費者對清潔標籤和機能性食品的需求不斷成長,聯合品牌發布和原料授權模式正逐漸成為可行的成長策略。
對特定真菌菌株和發酵基礎設施的依賴
真菌蛋白產業高度依賴專有真菌菌株和可控發酵環境,因此極易受到供應鏈中斷和規模化限制的影響。污染、設備故障和菌株不穩定都可能導致生產中斷,並影響產品的一致性。此外,發酵設施屬於資本密集型產業,這不僅對新參與企業構成准入壁壘,也限制了其地理擴張。圍繞菌株所有權和發酵通訊協定的智慧財產權糾紛還會進一步阻礙商業化進程。
新冠疫情對菌蛋白肉品替代品市場產生了雙重影響。一方面,供應鏈中斷和勞動力短缺暫時減緩了生產和分銷。另一方面,消費者對增強免疫力和永續食品日益成長的興趣促使人們更多地嘗試和使用替代蛋白。居家烹飪和電商通路的興起為冷凍和已烹調菌蛋白產品創造了新的商機。此外,疫情也加速了對食品科技和發酵新興企業的投資,增強了該產業的韌性和長期成長潛力。
預計在預測期內,菌蛋白碎肉/絞肉細分市場將是最大的細分市場。
由於其用途廣泛且與全球各地美食相容,預計在預測期內,菌蛋白碎肉/絞肉產品將佔據最大的市場佔有率。這些產品擴大用於漢堡、塔可餅、義式麵食麵醬、炒菜等食品中,以熟悉的形式作為肉類替代品。它們能夠吸收各種風味並模仿絞肉的口感,也深受彈性素食者和素食者的喜愛。製造商們也不斷創新調味料配方和烹飪方式,以提升消費者的體驗。
預計在預測期內,B2B食品供應商細分市場將以最高的複合年成長率成長。
受食品生產商對永續蛋白質原料需求不斷成長的推動,B2B原料供應商領域預計將在預測期內實現最高成長率。真菌蛋白質正被添加到混合肉類、零嘴零食和強化食品中,使其應用範圍超越了傳統的肉類替代品。原料供應商正投資於可擴展的發酵平台,以提供粉末、片狀和濃縮物等可客製化產品形式。該領域受益於長期供應協議、共同開發契約以及監管機構對新型食品原料的支持。
預計亞太地區將在預測期內佔據最大的市場佔有率,這主要得益於快速的都市化、中階日益增強的健康意識以及政府對永續食品體系的支持。中國、日本和韓國等國家正經歷植物來源產品上市量和零售貨架面積的激增。本土新興企業和跨國品牌正利用其在傳統發酵方面的專業知識和消費者對菌類食品的接受度,擴大在該地區的業務。
由於消費者對潔淨標示、高蛋白替代食品的濃厚興趣以及北美地區強大的食品技術創新生態系統,預計北美地區在預測期內將實現最高的複合年成長率。該地區擁有多家菌蛋白新興企業和發酵基礎設施供應商。零售商正在擴大其植物來源產品的供應,連鎖餐廳也正在試行以菌蛋白為基礎的菜單。有關新型食品的監管政策日益明朗,以及對永續農業投資的不斷增加,都進一步推動了市場擴張。
According to Stratistics MRC, the Global Mycoprotein Meat Substitutes Market is accounted for $1.78 billion in 2025 and is expected to reach $3.84 billion by 2032 growing at a CAGR of 11.6% during the forecast period. Mycoprotein meat substitutes are high-protein, meat-free alternatives derived from fermented fungi, typically Fusarium venenatum. Produced through controlled fermentation, mycoprotein offers a fibrous texture and umami flavor that mimics conventional meat. These substitutes are rich in essential amino acids, low in saturated fat, and often fortified with nutrients. Commonly used in burgers, nuggets, and mince-style products, they support sustainable food production by requiring fewer resources than livestock. Mycoprotein-based options cater to vegetarian, vegan, and health-conscious consumers seeking protein-rich alternatives.
Rising concerns over red meat consumption and its link to chronic diseases
Mycoprotein-based substitutes offer a compelling alternative, being rich in protein yet low in saturated fat and cholesterol. This transition is further supported by environmental concerns, as mycoprotein production has a significantly lower carbon footprint compared to livestock farming. The market is also benefiting from endorsements by health organizations and nutritionists advocating for sustainable protein sources. As a result, demand for fungi-derived meat alternatives is gaining traction across both retail and foodservice channels.
Taste and texture limitations
Consumers often cite inconsistencies in mouthfeel, flavor depth, and cooking behavior as barriers to adoption. These limitations are particularly pronounced in cultures with strong culinary traditions centered around meat. Moreover, the fermentation process used to produce mycoprotein can impart earthy or unfamiliar notes that may deter first-time buyers. While R&D efforts are underway to improve palatability, overcoming these sensory hurdles is critical for broader market acceptance and repeat purchases.
Partnerships between biotech firms and food manufacturers
Strategic collaborations between biotechnology startups and established food companies are unlocking new possibilities in product development and scalability. These partnerships enable the integration of precision fermentation, strain optimization, and flavor engineering into mainstream food production. Joint ventures are also facilitating access to advanced infrastructure, regulatory expertise, and global distribution networks. As consumer demand for clean-labels and functional foods co-branded launches and ingredient licensing models are emerging as viable growth strategies.
Dependence on specific fungi strains and fermentation infrastructure
The mycoprotein industry relies heavily on proprietary fungal strains and controlled fermentation environments, making it vulnerable to supply chain disruptions and scalability constraints. Any contamination, equipment failure, or strain instability can halt production and impact product consistency. Additionally, the capital-intensive nature of fermentation facilities poses entry barriers for new players and limits geographic expansion. Intellectual property disputes over strain ownership and fermentation protocols may further complicate commercialization.
The COVID-19 pandemic had a dual impact on the mycoprotein meat substitutes market. On one hand, supply chain interruptions and labor shortages temporarily slowed production and distribution. On the other, heightened consumer interest in immunity-boosting and sustainable foods led to increased trial and adoption of alternative proteins. The shift toward home cooking and e-commerce channels created new opportunities for frozen and ready-to-eat mycoprotein products. Moreover, the pandemic accelerated investment in food tech and fermentation startups, reinforcing the sector's resilience and long-term growth potential.
The mycoprotein mince/grounds segment is expected to be the largest during the forecast period
The mycoprotein mince/grounds segment is expected to account for the largest market share during the forecast period due to its versatility and compatibility with global cuisines. These products are increasingly used in burgers, tacos, pasta sauces, and stir-fries, offering a familiar format for meat replacement. Their ability to absorb flavors and mimic the texture of minced meat makes them appealing to flexitarians and vegetarians alike. Manufacturers are also innovating with seasoning blends and cooking formats to enhance consumer experience.
The B2B ingredient suppliers segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the B2B ingredient suppliers segment is predicted to witness the highest growth rate driven by rising demand from food manufacturers seeking sustainable protein inputs. Mycoprotein is being incorporated into hybrid meat products, snacks, and fortified meals, expanding its application beyond traditional meat analogs. Ingredient suppliers are investing in scalable fermentation platforms and offering customizable formats such as powders, flakes, and concentrates. This segment benefits from long-term supply contracts, co-development agreements, and regulatory support for novel food ingredients.
During the forecast period, the Asia Pacific region is expected to hold the largest market share fueled by rapid urbanization, growing middle-class health awareness, and government support for sustainable food systems. Countries like China, Japan, and South Korea are witnessing a surge in plant-based product launches and retail shelf space. Local startups and multinational brands are expanding operations in the region, leveraging traditional fermentation expertise and consumer openness to fungi-based foods.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR driven by strong consumer interest in clean-label, high-protein alternatives and a robust ecosystem of food tech innovation. The region hosts several leading mycoprotein startups and fermentation infrastructure providers. Retailers are expanding plant-based offerings, while foodservice chains are piloting mycoprotein-based menu items. Regulatory clarity around novel foods and increasing investment in sustainable agriculture further support market expansion.
Key players in the market
Some of the key players in Mycoprotein Meat Substitutes Market include Quorn Foods, Enough, MycoTechnology Inc., The Better Meat Co., Nature's Fynd, Prime Roots, Meati Foods, Atlast Food Co., MyForest Foods, Tyson Foods, Nestle, Beyond Meat, Kellogg's, Greenleaf Foods, Marlow Foods Ltd., Next Gen Foods, Perfect Day, ADM, Unilever, and ProVeg International.
In October 2025, Quorn launched its biggest frozen meat-free campaign in four years, featuring puppet mascots and multi-channel outreach. The campaign spans TV, social media, podcasts, and in-store activations across 1,500 UK supermarkets.
In September 2025, Enough Is Enough issued a press statement urging Congress to address child safety issues in Meta's VR platforms. The organization cited whistleblower testimony and called for regulatory action.
In June 2025, Prime Roots launched the first plant-based whole-cut deli meats that mimic traditional charcuterie. Products include Koji-based turkey, ham, and salami with clean labels. The launch follows 7 years of R&D and targets retail and foodservice.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.